IL PROPAFENONE NEL TRATTAMENTO ACUTO E NELLA PREVENZIONE DELLA TACHICARDIA PAROSSISTICA SOPRAVENTRICOLARE IN PAZIENTI CON SINDROME DI WOLFF-PARKINSON- WHITE

Translated title of the contribution: Propafenone in the acute treatment and prevention of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome

M. Palma, G. Palma, I. Oppo, M. M. Piscitelli, S. Nardi, E. Pisani, V. Santinelli

Research output: Contribution to journalArticlepeer-review

Abstract

Propafenone is very effective in the control of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome; intravenous Propafenone can predict the efficacy of oral therapy. Propafenone administration is not associated with major side effects.

Translated title of the contributionPropafenone in the acute treatment and prevention of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome
Original languageItalian
Pages (from-to)33-36
Number of pages4
JournalCuore
Volume12
Issue number1
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Propafenone in the acute treatment and prevention of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome'. Together they form a unique fingerprint.

Cite this